Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.
2.

Fatal Myocarditis Following Treatment with the PD-1 Inhibitor Nivolumab.

Matson DR, Accola MA, Rehrauer WM, Corliss RF.

J Forensic Sci. 2018 May;63(3):954-957. doi: 10.1111/1556-4029.13633. Epub 2017 Aug 17.

PMID:
28833116
3.

First described case of prosthetic joint infection with Clostridium disporicum.

McBride JA, Sterkel AK, Rehrauer WM, Smith JA.

Anaerobe. 2017 Dec;48:56-58. doi: 10.1016/j.anaerobe.2017.06.022. Epub 2017 Jul 1.

PMID:
28673848
4.

KRAS and GNAS Co-Mutation in Metastatic Low-Grade Appendiceal Mucinous Neoplasm (LAMN) to the Ovaries: A Practical Role for Next-Generation Sequencing.

Matson DR, Xu J, Huffman L, Barroilhet L, Accola M, Rehrauer WM, Weisman P.

Am J Case Rep. 2017 May 20;18:558-562.

5.

INSM1: A Novel Immunohistochemical and Molecular Marker for Neuroendocrine and Neuroepithelial Neoplasms.

Rosenbaum JN, Guo Z, Baus RM, Werner H, Rehrauer WM, Lloyd RV.

Am J Clin Pathol. 2015 Oct;144(4):579-91. doi: 10.1309/AJCPGZWXXBSNL4VD.

PMID:
26386079
6.

High-risk human papillomavirus DNA detected in primary squamous cell carcinoma of urinary bladder.

Chapman-Fredricks JR, Cioffi-Lavina M, Accola MA, Rehrauer WM, Garcia-Buitrago MT, Gomez-Fernandez C, Ganjei-Azar P, Jordà M.

Arch Pathol Lab Med. 2013 Aug;137(8):1088-93. doi: 10.5858/arpa.2012-0122-OA.

PMID:
23899065
7.

Naturally occurring genotype 2b/1a hepatitis C virus in the United States.

Bhattacharya D, Accola MA, Ansari IH, Striker R, Rehrauer WM.

Virol J. 2011 Oct 3;8:458. doi: 10.1186/1743-422X-8-458.

8.

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

Young KH, Leroy K, Møller MB, Colleoni GW, Sánchez-Beato M, Kerbauy FR, Haioun C, Eickhoff JC, Young AH, Gaulard P, Piris MA, Oberley TD, Rehrauer WM, Kahl BS, Malter JS, Campo E, Delabie J, Gascoyne RD, Rosenwald A, Rimsza L, Huang J, Braziel RM, Jaffe ES, Wilson WH, Staudt LM, Vose JM, Chan WC, Weisenburger DD, Greiner TC.

Blood. 2008 Oct 15;112(8):3088-98. doi: 10.1182/blood-2008-01-129783. Epub 2008 Jun 17.

9.

The major histocompatibility complex class II alleles Mamu-DRB1*1003 and -DRB1*0306 are enriched in a cohort of simian immunodeficiency virus-infected rhesus macaque elite controllers.

Giraldo-Vela JP, Rudersdorf R, Chung C, Qi Y, Wallace LT, Bimber B, Borchardt GJ, Fisk DL, Glidden CE, Loffredo JT, Piaskowski SM, Furlott JR, Morales-Martinez JP, Wilson NA, Rehrauer WM, Lifson JD, Carrington M, Watkins DI.

J Virol. 2008 Jan;82(2):859-70. Epub 2007 Nov 7.

10.

Molecular typing of major histocompatibility complex class I alleles in the Indian rhesus macaque which restrict SIV CD8+ T cell epitopes.

Kaizu M, Borchardt GJ, Glidden CE, Fisk DL, Loffredo JT, Watkins DI, Rehrauer WM.

Immunogenetics. 2007 Sep;59(9):693-703. Epub 2007 Jul 20.

PMID:
17641886
11.

Mamu-B*08-positive macaques control simian immunodeficiency virus replication.

Loffredo JT, Maxwell J, Qi Y, Glidden CE, Borchardt GJ, Soma T, Bean AT, Beal DR, Wilson NA, Rehrauer WM, Lifson JD, Carrington M, Watkins DI.

J Virol. 2007 Aug;81(16):8827-32. Epub 2007 May 30.

12.

The high frequency Indian rhesus macaque MHC class I molecule, Mamu-B*01, does not appear to be involved in CD8+ T lymphocyte responses to SIVmac239.

Loffredo JT, Sidney J, Piaskowski S, Szymanski A, Furlott J, Rudersdorf R, Reed J, Peters B, Hickman-Miller HD, Bardet W, Rehrauer WM, O'Connor DH, Wilson NA, Hildebrand WH, Sette A, Watkins DI.

J Immunol. 2005 Nov 1;175(9):5986-97.

13.

A dominant role for CD8+-T-lymphocyte selection in simian immunodeficiency virus sequence variation.

O'Connor DH, McDermott AB, Krebs KC, Dodds EJ, Miller JE, Gonzalez EJ, Jacoby TJ, Yant L, Piontkivska H, Pantophlet R, Burton DR, Rehrauer WM, Wilson N, Hughes AL, Watkins DI.

J Virol. 2004 Dec;78(24):14012-22.

14.

Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses.

O'Connor DH, Mothe BR, Weinfurter JT, Fuenger S, Rehrauer WM, Jing P, Rudersdorf RR, Liebl ME, Krebs K, Vasquez J, Dodds E, Loffredo J, Martin S, McDermott AB, Allen TM, Wang C, Doxiadis GG, Montefiori DC, Hughes A, Burton DR, Allison DB, Wolinsky SM, Bontrop R, Picker LJ, Watkins DI.

J Virol. 2003 Aug;77(16):9029-40.

15.

Modulation of RecA nucleoprotein function by the mutagenic UmuD'C protein complex.

Rehrauer WM, Bruck I, Woodgate R, Goodman MF, Kowalczykowski SC.

J Biol Chem. 1998 Dec 4;273(49):32384-7.

17.

Interaction of Escherichia coli RecA protein with LexA repressor. I. LexA repressor cleavage is competitive with binding of a secondary DNA molecule.

Rehrauer WM, Lavery PE, Palmer EL, Singh RN, Kowalczykowski SC.

J Biol Chem. 1996 Sep 27;271(39):23865-73.

18.

The DNA binding site(s) of the Escherichia coli RecA protein.

Rehrauer WM, Kowalczykowski SC.

J Biol Chem. 1996 May 17;271(20):11996-2002.

19.

Biochemistry of homologous recombination in Escherichia coli.

Kowalczykowski SC, Dixon DA, Eggleston AK, Lauder SD, Rehrauer WM.

Microbiol Rev. 1994 Sep;58(3):401-65. Review.

Supplemental Content

Loading ...
Support Center